BridgeBio Pharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2019 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BridgeBio Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2019 to Q2 2024.
  • BridgeBio Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 25, 2024 was 188M shares, a 15.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 188M +25.6M +15.7% Jul 25, 2024 10-Q 2024-08-01
Q1 2024 187M +26.6M +16.6% Apr 25, 2024 10-Q 2024-05-02
Q3 2023 174M +24.5M +16.4% Oct 26, 2023 10-Q 2023-11-02
Q2 2023 162M +14.2M +9.6% Jul 31, 2023 10-Q 2023-08-03
Q1 2023 161M +12.8M +8.67% Apr 24, 2023 10-Q 2023-05-04
Q3 2022 149M +2.32M +1.57% Oct 28, 2022 10-Q 2022-11-03
Q2 2022 148M -1.52M -1.01% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 148M -1.59M -1.07% Apr 29, 2022 10-Q 2022-05-05
Q3 2021 147M +24.6M +20.1% Oct 29, 2021 10-Q 2021-11-04
Q2 2021 150M +27.4M +22.4% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 149M +25.5M +20.6% Apr 30, 2021 10-Q 2021-05-06
Q3 2020 123M -1.01M -0.82% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 122M +5.61M +4.8% Aug 5, 2020 10-Q 2020-08-11
Q1 2020 124M Feb 24, 2020 10-K 2020-03-03
Q3 2019 124M Nov 5, 2019 10-Q 2019-11-08
Q2 2019 117M Aug 9, 2019 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.